Tonix Pharmaceuticals Holding Corp. Business Finance Contracts & Agreements
86 Contracts & Agreements
- Assignment Agreements (1 contract)
- Debenture Agreements (2)
- Escrow Agreements (1)
- Exchange Agreements (1)
- Guaranty Agreements (1)
- Note Agreements (1)
- Purchase Agreements (21)
- Registration Rights Agreements (10)
- Release Agreements (1)
- Security Agreements (1)
- Stock Agreements (6)
- Subscription Agreements (3)
- Underwriting Agreements (16)
- Warrant Agreements (21)
- Placement Agent Agreement, dated July 27, 2023, among Tonix Pharmaceuticals Holding Corp., A.G.P./Alliance Global Partners and Brookline Capital Markets, a division of Arcadia... (Filed With SEC on July 28, 2023)
- Placement Agent Agreement, dated July 27, 2023, among Tonix Pharmaceuticals Holding Corp., A.G.P./Alliance Global Partners and Brookline Capital Markets, a division of Arcadia... (Filed With SEC on July 28, 2023)
- Placement Agent Agreement, dated July 27, 2023, among Tonix Pharmaceuticals Holding Corp., A.G.P./Alliance Global Partners and Brookline Capital Markets, a division of Arcadia... (Filed With SEC on July 28, 2023)
- Placement Agent Agreement, dated July 27, 2023, among Tonix Pharmaceuticals Holding Corp., A.G.P./Alliance Global Partners and Brookline Capital Markets, a division of Arcadia... (Filed With SEC on July 28, 2023)
- Asset Purchase Agreement, dated as of June 23, 2023, by and among Upsher-Smith Laboratories, LLC, Tonix Medicines, Inc. and Tonix Pharmaceuticals Holding Corp. Press Release of... (Filed With SEC on June 26, 2023)
- Form of Securities Purchase Agreement between Tonix Pharmaceuticals Holding Corp. and the investors thereto, dated October 25, 2022 (Filed With SEC on October 25, 2022)
- Form of Registration Rights Agreement between Tonix Pharmaceuticals Holding Corp. and the investors thereto, dated October 25, 2022 (Filed With SEC on October 25, 2022)
- Purchase Agreement, dated August 16, 2022, by and between Tonix Pharmaceuticals Holding Corp. and Lincoln Park Capital Fund, LLC (Filed With SEC on August 17, 2022)
- Registration Rights Agreement, dated August 16, 2022, by and between Tonix Pharmaceuticals Holding Corp. and Lincoln Park Capital Fund, LLC (Filed With SEC on August 17, 2022)
- Form of Certificate of Designation of Series A Convertible Redeemable Preferred Stock Form of Certificate of Designation of Series B Convertible Redeemable Preferred Stock Form of... (Filed With SEC on June 22, 2022)
- Form of Certificate of Designation of Series A Convertible Redeemable Preferred Stock Form of Certificate of Designation of Series B Convertible Redeemable Preferred Stock Form of... (Filed With SEC on June 22, 2022)
- Form of Certificate of Designation of Series A Convertible Redeemable Preferred Stock Form of Certificate of Designation of Series B Convertible Redeemable Preferred Stock Form of... (Filed With SEC on June 22, 2022)
- Purchase Agreement, dated December 3, 2021, by and between Tonix Pharmaceuticals Holding Corp. and Lincoln Park Capital Fund, LLC (Filed With SEC on December 3, 2021)
- Registration Rights Agreement, dated December 3, 2021, by and between Tonix Pharmaceuticals Holding Corp. and Lincoln Park Capital Fund, LLC (Filed With SEC on December 3, 2021)
- Purchase and Sale Agreement, dated July 26, 2021, between the Company and Southern Research (Filed With SEC on August 9, 2021)
- Purchase Agreement, dated May 14, 2021, by and between Tonix Pharmaceuticals Holding Corp. and Lincoln Park Capital Fund, LLC (Filed With SEC on May 14, 2021)
- Registration Rights Agreement, dated May 14, 2021, by and between Tonix Pharmaceuticals Holding Corp. and Lincoln Park Capital Fund, LLC (Filed With SEC on May 14, 2021)
- Purchase and Sale Agreement, dated March 5, 2021, between Tonix Pharmaceuticals Holding Corp. and the Seller named therein (Filed With SEC on March 15, 2021)
- Form of Securities Purchase Agreement, dated February 8, 2021, by and between the Company and the Purchasers thereunder (Filed With SEC on February 9, 2021)
- Form of Securities Purchase Agreement, dated January 11, 2021, by and between the Company and the Purchasers thereunder (Filed With SEC on January 12, 2021)
- Purchase and Sale Agreement, dated October 14, 2020 (Filed With SEC on November 9, 2020)
- Purchase Agreement, dated September 3, 2020, by and between Tonix Pharmaceuticals Holding Corp. and Lincoln Park Capital Fund, LLC (Filed With SEC on September 4, 2020)
- Registration Rights Agreement, dated September 3, 2020, by and between Tonix Pharmaceuticals Holding Corp. and Lincoln Park Capital Fund, LLC (Filed With SEC on September 4, 2020)
- Purchase and Sale Agreement, dated July 1, 2020 (Filed With SEC on August 10, 2020)
- Asset Purchase Agreement, dated June 11, 2020, between the Company and Trigemina, Inc (Filed With SEC on August 10, 2020)
- Assignment and Agreement, dated June 11, 2020, between the Company and The Board of Trustees of the Leland Stanford Junior University (Filed With SEC on August 10, 2020)
- Form of Securities Purchase Agreement, dated July 13, 2020, by and between the Company and the Purchasers thereunder (Filed With SEC on July 14, 2020)
- Form of Securities Purchase Agreement, dated February 28, 2020, by and between the Company and the Purchasers thereunder (Filed With SEC on February 28, 2020)
- Form of Underwriting Agreement (Filed With SEC on February 6, 2020)
- Form of Warrant (Filed With SEC on February 6, 2020)
- Form of Warrant Agency Agreement (Filed With SEC on February 6, 2020)
- Form of Warrant (Filed With SEC on November 15, 2019)
- Form of Common Warrant (Filed With SEC on November 15, 2019)
- Form of Underwriting Agreement (Filed With SEC on November 14, 2019)
- Form of Warrant (Filed With SEC on November 14, 2019)
- Form of Common Stock Purchase Warrant (Filed With SEC on November 14, 2019)
- Form of Warrant Agency Agreement (Filed With SEC on November 14, 2019)
- Form of Warrant Agreement (Filed With SEC on November 14, 2019)
- Asset Purchase Agreement, dated August 19, 2019, between Tonix Pharmaceuticals Holding Corp. and TRImaran Pharma, Inc (Filed With SEC on November 8, 2019)
- Purchase Agreement, dated August 20, 2019, by and between Tonix Pharmaceuticals Holding Corp. and Lincoln Park Capital Fund, LLC (Filed With SEC on August 23, 2019)
